Literature DB >> 7578872

Low dose streptozotocin causes diabetes in severe combined immunodeficient (SCID) mice without immune cell infiltration of the pancreatic islets.

S Reddy1, D Wu, R B Elliott.   

Abstract

Streptozotocin (stz) given in low doses (40 mg/kg body weight) on 5 consecutive days to susceptible strains of mice causes diabetes. Previous studies have shown that the induction of diabetes is associated with inflammatory infiltrates within the pancreatic islets. However, it is unclear whether stz causes limited beta cell destruction followed by insulitis or whether the diabetogen promotes immune cell influx into the pancreatic islets, followed by immune-mediated beta-cell destruction. It is also unclear whether stz given in sub-diabetogenic doses is capable of causing diabetes independent of cell-mediated processes. Here we have examined these possibilities in CB.17 Scid mice which lack functional T and B cells but have immunocompetent macrophages and NK cells. Low dose stz given to Scid mice caused diabetes in approximately 50% of mice of both sexes by 21 days (14/24 males; 10/18 females). Sections of pancreas were examined immunohistochemically for the presence of MAC-1 positive cells (macrophages and natural killer cells) in the exocrine, peri- and intra-islet regions at different time points following the administration of stz. There were no statistically significant differences in the number of immunoreactive cells in the three locations between tissues obtained from stz-injected mice (3, 7, 14 and 21 days after stz injection and at onset of diabetes) and buffer-injected Scid mice. Although diabetic Scid mice showed a reduced number of insulin immunoreactive cells and peri- and intra-islet distributed glucagon cells, no insulitis was seen histochemically. In parallel studies, normal Swiss male mice given stz at a similar dose developed diabetes (10/10) associated with insulitis which consisted predominantly of CD4, CD8 and MAC-1 cells. Balb/c mice given stz similarly, also developed diabetes (5/8) without showing insulitis, although a moderate increase in the number of macrophages were observed within several islets. These studies demonstrate that stz administered in multiple low doses to Scid mice can cause beta cell destruction and diabetes in the absence of immune cell infiltrate within the pancreatic islets.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7578872     DOI: 10.3109/08916939509001931

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  16 in total

1.  CD18 deficiency protects against multiple low-dose streptozotocin-induced diabetes.

Authors:  Shayne C Barlow; Will Langston; Kametra M Matthews; John H Chidlow; Christopher G Kevil
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

2.  Description of the sphingolipid content and subspecies in the diabetic cornea.

Authors:  Shrestha Priyadarsini; Akhee Sarker-Nag; Jeremy Allegood; Charles Chalfant; Dimitrios Karamichos
Journal:  Curr Eye Res       Date:  2014-11-26       Impact factor: 2.424

3.  In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage-derived cytokines in a model of organ-specific insulitis.

Authors:  R Ludwig; M Kretschmer; G Caspar; J Bojunga; A Oldenburg; P Schumm-Draeger; M Stegmüller; G von Minckwitz; K H Usadel; K Kusterer
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

Review 4.  Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models.

Authors:  M C Deeds; J M Anderson; A S Armstrong; D A Gastineau; H J Hiddinga; A Jahangir; N L Eberhardt; Y C Kudva
Journal:  Lab Anim       Date:  2011-04-08       Impact factor: 2.471

5.  The use of animal models in diabetes research.

Authors:  Aileen J F King
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

6.  Streptozotocin is equally diabetogenic whether administered to fed or fasted mice.

Authors:  Zunaira Z Chaudhry; David L Morris; Dan R Moss; Emily K Sims; Yien Chiong; Tatsuyoshi Kono; Carmella Evans-Molina
Journal:  Lab Anim       Date:  2013-06-10       Impact factor: 2.471

7.  Bacille Calmette-Guérin/DNAhsp65 prime-boost is protective against diabetes in non-obese diabetic mice but not in the streptozotocin model of type 1 diabetes.

Authors:  L C da Rosa; F Chiuso-Minicucci; S F G Zorzella-Pezavento; T G D França; L L W Ishikawa; P M Colavite; B Balbino; L C B Tavares; C L Silva; C Marques; M R V Ikoma; A Sartori
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

8.  Roles of Bcl-3 in the pathogenesis of murine type 1 diabetes.

Authors:  Qingguo Ruan; Shi-Jun Zheng; Scott Palmer; Ruaidhri J Carmody; Youhai H Chen
Journal:  Diabetes       Date:  2010-07-09       Impact factor: 9.461

9.  Streptozotocin, type I diabetes severity and bone.

Authors:  Katherine Motyl; Laura R McCabe
Journal:  Biol Proced Online       Date:  2009-03-06       Impact factor: 3.244

Review 10.  Current status and patent prospective of animal models in diabetic research.

Authors:  Radhey S Dhuria; Gurpreet Singh; Anudeep Kaur; Ramandeep Kaur; Tanurajvir Kaur
Journal:  Adv Biomed Res       Date:  2015-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.